Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Alicia Rovo, MD, Thomas Daikeler, MD, Joerg Halter, MD, Dominik Heim, MD, Jan Dirk Studt, MD, Michael Medinger, MD, Caroline Arber, MD, Martin Stern, MD, Dimitrios Tsakiris, MD, Alan Tyndall, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2008) 112 (11): 4298.

https://doi.org/10.1182/blood.V112.11.4298.4298

Published: 2008

Journal Articles

Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis

Alicia Rovó, Thomas Daikeler, Martin Stern, Jörg Halter, Jan Dirk Studt, Andreas Buser, Dominik Heim, Johannes Rischewski, Michael Medinger, Alan Tyndall, Alois Gratwohl, André Tichelli

Blood (2008) 111 (3): 1740–1741.

https://doi.org/10.1182/blood-2007-10-115964

Published: 2008

Journal Articles

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Gerhard Antoine, Martin Hermann, Manfred Rieger, Friedrich Scheiflinger, Bernhard Lämmle

Blood (2005) 105 (2): 542–544.

https://doi.org/10.1182/blood-2004-06-2096

Published: 2005

Journal Articles

Factor V Leiden Is Not a Risk Factor for Thrombotic Microangiopathies without Severe ADAMTS13 Deficiency.

Johanna A. Kremer Hovinga, MD, Soraya Krieg, MD, Jan-Dirk Studt, MD, Irmela Sulzer, Bernhard Lammle, MD

Blood (2004) 104 (11): 850.

https://doi.org/10.1182/blood.V104.11.850.850

Published: 2004

Journal Articles

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich Dorner, Bernhard Lämmle, Pier Mannuccio Mannucci, Friedrich Scheiflinger

Blood (2004) 103 (12): 4514–4519.

https://doi.org/10.1182/blood-2003-12-4165

Published: 2004

Journal Articles

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Radovan Radonic, Vladimir Gasparovic, Dragutin Ivanovic, Marijan Merkler, Urs Wirthmueller, Clemens Dahinden, Miha Furlan, Bernhard Lämmle

Blood (2004) 103 (11): 4195–4197.

https://doi.org/10.1182/blood-2003-11-3888

Published: 2004

Journal Articles

Discrepant activity levels of von Willebrand factor–cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Miha Furlan, Bernhard Lämmle

Blood (2003) 102 (3): 1148.

https://doi.org/10.1182/blood-2003-05-1466

Published: 2003

Journal Articles

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Sara K. Vesely, James N. George, Bernhard Lämmle, Jan-Dirk Studt, Lorenzo Alberio, Mayez A. El-Harake, Gary E. Raskob

Blood (2003) 102 (1): 60–68.

https://doi.org/10.1182/blood-2003-01-0193

Published: 2003

NARROW

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Factor V Leiden Is Not a Risk Factor for Thrombotic Microangiopathies without Severe ADAMTS13 Deficiency.

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Discrepant activity levels of von Willebrand factor–cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only